DRREDDY / FY26 summary

The year in one view.

Dr. Reddy's Laboratories · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

16,853

₹ Cr where applicable

PAT across quarters

1,626

₹ Cr where applicable

Source quarters

2

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 2,049 · Watch source sentiment · 2026-01-22Q3 FY26Q1 FY27: 1,109 · Watch source sentiment · 2026-07-31Q1 FY272,0491,109
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.